Navigation Links
Masimo Files Patent Infringement Suit Against Philips
Date:2/3/2009

including any appeals; the ability of our patents to protect our intellectual property and products; our ability to enforce our intellectual property rights; and the risks associated with litigation in general, including the costs and time that must be devoted to litigation, the potential diversion of the attention of management and key employees that may result from being engaged in litigation, and the possibility of adverse results. Additional factors that may cause Masimo's actual results to differ materially from those expressed in forward-looking statements include, but are not limited to: those factors discussed in the "Risk Factors" section of our Quarterly Report on Form 10-Q for the fiscal quarter ended September 27, 2008, filed with the Securities and Exchange Commission ("SEC") on October 29, 2008, which may be obtained for free at the SEC's website at www.sec.gov. Although we believe that the expectations reflected in our forward-looking statements are reasonable, we do not know whether our expectations will prove correct. All forward-looking statements included in this press release are expressly qualified in their entirety by the foregoing cautionary statements. You are cautioned not to place undue reliance on these forward-looking statements, which speak only as of today's date. We do not undertake any obligation to update, amend or clarify these forward-looking statements or the "Risk Factors" contained in our Quarterly Report on Form 10-Q for the fiscal quarter ended September 27, 2008, whether as a result of new information, future events or otherwise, except as may be required under the applicable securities laws.

    Contact:
    Steve Moran, Executive Vice President, General Counsel & Secretary
    Masimo Corporation
    949-297-7015

Masimo, SET, Signal Extraction Technology, Improving Outcomes and Reducing Cost of Care by Taking Noninvasi
'/>"/>

SOURCE Masimo
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine news :

1. Clinicians at Dartmouth-Hitchcock Medical Center Present New Data Showing Masimo Rainbow SET(R) Oximetry and Patient SafetyNet(TM) Improves Patient Outcomes and Reduces the Cost of Care
2. Masimo to Present at Lazard Capital Markets 5th Annual Healthcare Conference
3. Masimo Launches First Non-adhesive Pulse Oximetry Sensor Designed For Extremely Low Birth Weight Babies
4. Masimo Reports Second Quarter 2008 Financial Results
5. Aurora Health Care Completes System-Wide Conversion to Masimo SET Pulse Oximetry Technology
6. First Nursing Facility Installation of Masimo Patient SafetyNet(TM) Goes Live With Remarkable Results
7. Dartmouth-Hitchcock Medical Center Evaluation Findings Demonstrate Masimo Patient SafetyNet(TM) Delivers Improvements in Clinical Outcomes and Patient Safety on General Care Floors
8. Masimo Receives FDA Clearance for Noninvasive Total Hemoglobin
9. Saint Barnabas Medical Center Converts to Masimo SET Technology - Establishing a Foundation for the Future of Pulse Oximetry
10. Masimo to Report First Quarter 2008 Financial Results on April 29, 2008
11. Masimo to Report Fourth Quarter and Fiscal Year 2007 Financial Results on February 26, 2008
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/17/2014)... of the most popular vaccine brands for children may ... be overlooking some cost factors when choosing vaccines, driving ... option, according to a new study by University of ... can be driven by numerous factors," says Sheldon H. ... of computer science and of mathematics at the U. ...
(Date:4/17/2014)... (April 17, 2014) Two recent papers by ... and colleagues may help scientists develop treatments or ... fever, Japanese encephalitis and other disease-causing flaviviruses. , ... and molecular genetics at the School of Medicine ... Hughes Medical Institute, and colleagues recently published articles ...
(Date:4/17/2014)... April 17, 2014U.S. military personnel who served in ... concussive traumatic brain injury (TBI) were compared to ... other medical reasons. Differences in measures of overall ... months after injury are reported in an article ... journal from Mary Ann Liebert, Inc., publishers. The ...
(Date:4/17/2014)... April 17, 2014-- Colic affects about one in five ... numerous pediatric visits during the first several months after ... symptoms was showing promise; however, the April 1, 2014 ... Sung, Valerie) reported on a study, "Probiotics and Infant ... L reuteri for infant colic did not ...
(Date:4/17/2014)... (SACRAMENTO, Calif.) An international team led by researchers ... protein complex, which plays a key role in cell ... process. This is the first time the complex has ... could make cyclin B1/Cdk1 an excellent target to control ... medicine. The research was published online today in the ...
Breaking Medicine News(10 mins):Health News:Study recalculates costs of combination vaccines 2Health News:CU researchers discover target for treating dengue fever 2Health News:Long-term effects of battle-related 'blast plus impact' concussive TBI in US military 2Health News:New study says probiotic use for infant colic is not effective in reducing symptoms 2Health News:Dual role: Key cell division proteins also power up mitochondria 2
... recurrence of an employee,s medical leave of absence from work tends ... physical one, a Centre for Addiction and Mental Health (CAMH) study ... from their jobs do not have another disability leave for at ... contrast, most who have had a physical health disability leave have ...
... Reporter , TUESDAY, June 28 (HealthDay News) -- A vaccine ... some promise, while another designed to alter insulin production fails, ... results of both studies were slated to be presented Tuesday ... Type 1 diabetes often appears early in life and ...
... with life,s punches, while for others, every misfortune is a jab ... although most people require significant adversity to become depressed the ... 30 percent of people with first-time depression and 60 percent of ... minor misfortunes. But no one knew why. Now, ...
... , TUESDAY, June 28 (HealthDay News) -- ... to the flu vaccine, which suggests that the drugs ... as previously believed, researchers say. The small study ... were treated with sunitinib and six who were treated ...
... Diego, Calif., has joined a national consortium of research institutions ... library of primary human tumors with the goal of developing ... consortium member, STSI will provide solid human tumor samples to ... study. STSI scientists will then have access to the models ...
... Science University have discovered a naturally occurring disease in monkeys ... a discovery that could have a major impact on efforts ... disease that the researchers discovered in monkeys at OHSU,s Oregon ... that could give significant clues into how multiple sclerosis develops ...
Cached Medicine News:Health News:Workplace mental health disability leave recurs sooner than physical health leave, CAMH study shows 2Health News:Trials of Type 1 Diabetes Vaccines Bring Mixed Results 2Health News:Trials of Type 1 Diabetes Vaccines Bring Mixed Results 3Health News:Sweating the small stuff: Early adversity, prior depression linked to high sensitivity to stress 2Health News:Sweating the small stuff: Early adversity, prior depression linked to high sensitivity to stress 3Health News:Certain Cancer Drugs Don't Interfere With Flu Vaccine: Study 2Health News:Scripps Translational Science Institute joins Jackson Laboratory tumor consortium 2Health News:Researchers at Oregon Health & Science University discover MS-like disease in monkeys 2
(Date:1/15/2014)... LOUISVILLE, Ky. , Jan. 15, 2014  Manufacturers, ... technologies must be able to protect their most ... (Logo: http://photos.prnewswire.com/prnh/20130716/CL46586LOGO ) Because ... Industry, it steadfastly remains one of the most ...
(Date:1/15/2014)... , Jan. 15, 2014 MultiCell Technologies, Inc. (OTC ... U.S. provisional patent application concerning composition of matter, biological ... targeted tumor cell death.  This patent ... double stranded RNA molecules (VSRNAs) which interfere with the ...
(Date:1/15/2014)... 2014  According to Millennium Research Group (MRG), the ... the United States and European ... expand moderately through 2022, with embolization particles representing ... interest in drug-eluting beads (DEBs) and radioembolization spheres ...
Breaking Medicine Technology:Intellectual Property Insurance for Medical-related Products and Services 2MultiCell Technologies Files Patent Application Covering New Class of RNA Therapeutics 2MultiCell Technologies Files Patent Application Covering New Class of RNA Therapeutics 3US and European Transcatheter Embolization and Occlusion Device Market to Surpass $1.6 Billion by 2022 2US and European Transcatheter Embolization and Occlusion Device Market to Surpass $1.6 Billion by 2022 3
Low pressure automatic tourniquet with manual time. Includes extension hose and spiral replacement hose....
... Safety. Convenience. Reliability. Cost. These are the ... personnel, and administrators. With a special focus ... practical elements of todays technology to develop ... The A.T.S. 2000 Tourniquet uses ambient air ...
... Retractor System has been designed so the ... delicate soft tissue away from the operative ... the procedure without stay-sutures or assistance. This ... the freedom to do other tasks, which ...
... Battery System is a revolutionary new addition ... surgical instruments. The PowerPro Battery System is ... powered instrument available on the market. It ... designed to meet the requirements of large ...
Medicine Products: